Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (990) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (290) Clinical Cancer Research (260) Immunology, Allergy, Rheumatology (207) Skin Cancer and Melanoma Prevention (172) ENT (Ear, Nose, Throat) (51) Chemotherapy and Side Effects Management (153)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/91035, first published .
Hand squeezing white cream from tube onto fingertip

Topical Esomeprazole for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer: Protocol for a Phase 2 Randomized Controlled Trial

Topical Esomeprazole for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer: Protocol for a Phase 2 Randomized Controlled Trial

Authors of this article:

Aaron Cheng1 Author Orcid Image ;   Pavela Bambekova2 Author Orcid Image ;   Yohannes T Ghebre3, 4 Author Orcid Image ;   Mark D Bonnen3 Author Orcid Image ;   Timothy Wagner3 Author Orcid Image ;   Sandra Osswald5 Author Orcid Image ;   Carol Jenkins3 Author Orcid Image ;   Pia Roperes3 Author Orcid Image ;   Shraddha Dalwadi3 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Aaron Cheng   1 , BA, BS ;   Pavela Bambekova   2 , MD ;   Yohannes T Ghebre   3, 4 , PhD ;   Mark D Bonnen   3 , MD ;   Timothy Wagner   3 , MBA, MD ;   Sandra Osswald   5 , MD ;   Carol Jenkins   3 , RN ;   Pia Roperes   3 , RN ;   Shraddha Dalwadi   3 , MBA, MD

1 Long School of Medicine, The University of Texas Health at San Antonio, San Antonio, TX, United States

2 Division of Dermatology, University of Texas Health at San Antonio, San Antonio, TX, United States

3 Department of Radiation Oncology, The University of Texas Health at San Antonio, San Antonio, TX, United States

4 School of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States

5 Division of Dermatology, The University of Texas Health at San Antonio, San Antonio, TX, United States

Corresponding Author:

  • Shraddha Dalwadi, MBA, MD
  • Department of Radiation Oncology
  • The University of Texas Health at San Antonio
  • 7979 Wurzbach Rd
  • San Antonio, TX 78229
  • United States
  • Phone: 1 210-450-1000
  • Email: dalwadi@uthscsa.edu